Trial intelligence / Profile preview

Lodotra modified-release prednisone in nocturnal asthma

2007-007316-29Phase 2Completed

Sponsor
Nitec Pharma
Start
Mar 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of prednisone in asthma (2 arms), sponsored by Nitec Pharma. Primary endpoint: Nocturnal awakenings. Started Mar 2008; status: completed.

02

Drugs

prednisone
03

Conditions

asthma

Beyond the preview

Go deeper on 2007-007316-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-007316-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call